In addition to the federal government, state regulators and state insurance commissioners should play a role when considering regulation of recently proposed health insurance mergers, said Sarah Lueck, senior policy analyst from the Center on Budget and Policy Priorities.
In addition to the federal government, state regulators and state insurance commissioners should play a role when considering regulation of recently proposed health insurance mergers, said Sarah Lueck, senior policy analyst from the Center on Budget and Policy Priorities.
Transcript (slightly modified)
With some very big healthcare mergers announced in 2015, do you think the government may try to regulate this space a little more?
I can't really say what the federal government will do, obviously it's under review and everything that's going is so private, so it's hard to know what the back and forth might be, what kinds of questions they're asking, what kind of information insurers are providing. It's all difficult to kind of see that process.
But I do hope that the federal government is taking a close look at this issue and, obviously, state regulators have a role as well. State attorneys general are looking at the competition issue, and state insurance commissioners in some cases are raising questions about a specific market. And that's really important because health insurance markets are so local, are so specific that it's really helpful to have a regulator that's in that place, looking closely at what's happening in that market to decide not only about the competitive issues taht might arise, but other issues that might arise that could impact consumers, like premium prices or network changes, or other things, and to also make sure, potentially, that if mergers go forward, that any issues that arise regulatorily could maybe be dealt with. They could maybe do somethings that if there's an issue where they haven't been doing a good job that they can make sure they do going forward. Or that there are transitions from one insurer to another and consumers are well taken care of.
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
What the Updated Telephone Consumer Protection Act Rules Mean for Health Care Messaging
April 4th 2025As new Federal Communications Commission rules take effect April 11, 2025, mPulse CEO Bob Farrell explains how health organizations can stay compliant while building patient trust through transparency and personalized engagement.
Read More